Endothelial function in patients with proteinuric primary glomerulonephritis

Nephron - Clinical Practice

Volumn 109, Issue 1, 2008, Pages

  Mackinnon, Bruce ^a   Deighan, Christopher J ^a   Ferrell, William R ^b   Sattar, Naveed ^a   Fox, Jonathan G ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Endothelial function; Laser Doppler iontophoresis; Proteinuria

Indexed keywords

ACETYLCHOLINE; BIOLOGICAL MARKER; INTERCELLULAR ADHESION MOLECULE 1; NITROPRUSSIDE SODIUM; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS; HUMAN; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEINURIA; SKIN BLOOD FLOW; VASCULAR ENDOTHELIUM;

CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROTEINURIA;

EID: 46349090275     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000135632     Document Type: Article

References (23)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112-S119.
2. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N: Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005;20:1048-1056.
3. Zeiher AM, Drexler H, Wollschlager H, Just H: Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991;84:1984-1992.
4. Pecoits-Filho R, Lindholm B, Stenvinkel P: The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter. Nephrol Dial Transplant 2002;17(suppl 11):28-31.
5. Morris ST, McMurray JJ, Spiers A, Jardine AG: Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int 2001;60:1077-1082.
6. Morris ST, McMurray JJ, Rodger RS, Jardine AG: Impaired endothelium-dependent vasodilatation in uraemia. Nephrol Dial Transplant 2000;15:1194-1200.
7. Mackinnon B, Deighan CJ, Norrie J, Boulton-Jones JM, Sattar N, Fox JG: The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis. Clin Nephrol 2005;63:173-180.
8. Dogra GK, Herrmann S, Irish AB, Thomas MA, Watts GF: Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant 2002;17:2220-2225.
9. Paisley KE, Beaman M, Tooke JE, Mohamed-Ali V, Lowe GD, Shore AC: Endothelial dysfunction and inflammation in asymptomatic proteinuria. Kidney Int 2003;63:624-633.
10. Ramsay JE, Ferrell WR, Greer IA, Sattar N: Factors critical to iontophoretic assessment of vascular reactivity: implications for clinical studies of endothelial dysfunction. J Cardiovasc Pharmacol 2002;39:9-17.
11. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
12. Sattar N, Perera M, Small M, Lumsden MA: Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes. Lancet 1999;354:487-488.
13. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN: Abnormalities of endothelial function in patients with predialysis renal failure. Heart 2000;83:205-209.
14. van Guldener C, Lambert J, Janssen MJ, Donker AJ, Stehouwer CD: Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant 1997;12(suppl 2):14-18.
15. Kielstein JT, Boger RH, Bode-Boger SM, Frolich JC, Haller H, Ritz E, Fliser D: Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 2002;13:170-176.
16. Bijlstra PJ, Smits P, Lutterman JA, Thien T: Effect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndrome. J Cardiovasc Pharmacol 1995;25:658-664.
17. Luscher TF, Tanner FC, Noll G: Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions. Curr Opin Lipidol 1996;7:234-240.
18. Ramsay JE, Simms RJ, Ferrell WR, Crawford L, Greer IA, Lumsden MA, Sattar N: Enhancement of endothelial function by pregnancy: inadequate response in women with type 1 diabetes. Diabetes Care 2003;26:475-479.
19. Morris SJ, Shore AC, Tooke JE: Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 1995;38:1337-1344.
20. Jadhav ST, Ferrell WR, Petrie JR, Scherbakova O, Greer IA, Cobbe SM, Sattar N: Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. Am J Cardiol 2006;97:1727-1731.
21. Schachinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-1906.
22. Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD: Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes 2000;49:485-491.
23. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.